Revance Therapeutics Inc (NASDAQ: RVNC) stock suffered a major decline of -17.0% on 11/9/23. The shares closed at $6.91. The stock has been extremely weak relative to the market over the last nine months and […]
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock suffered a major decline of -21.9% on 11/9/23. The shares closed at $3.38. The stock has been weak relative to the market over the last nine months and has […]
ProAssurance Corp (NYSE: PRA) stock closed at $13.91 on 11/9/23 after a major decline of -21.3%. The stock has declined -19.5% during the last week but has been strong relative to the market over the […]
James River Group Holdings Ltd (NASDAQ: JRVR) stock closed at $8.84 on 11/9/23 after a major decline of -32.8%. The stock has declined -35.8% during the last week and has been extremely weak relative to […]
Amicus Therapeutics Inc (NASDAQ: FOLD) stock suffered a major decline of -12.2% on 11/9/23. The shares closed at $9.98. The stock has been strong relative to the market over the last nine months but has […]
Full House Resorts Inc (NASDAQ: FLL) stock enjoyed a major increase of 18.7% on 11/9/23. The shares closed at $4.64. The stock has risen 28.9% during the last week but has been extremely weak relative […]
On 11/9/23, Phibro Animal Health Corp (NASDAQ: PAHC) stock suffered a major decline of -18.5%, closing at $9.81. The stock has been weak relative to the market over the last nine months and has declined […]
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) stock suffered a major decline of -14.1% on 11/9/23. The shares closed at $5.93. The stock has been strong relative to the market over the last nine months but has […]
On 11/9/23, CareDx Inc (NASDAQ: CDNA) stock enjoyed a major increase of 13.9%, closing at $7.21. Relative to the market the stock has been extremely weak over the last nine months but has risen 33.3% […]
Computer Programs and Systems In (NASDAQ: CPSI) stock closed at $11.67 on 11/9/23 after a major decline of -11.5%. The stock has declined -17.6% during the last week and has been extremely weak relative to […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research